scholarly journals A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin

Cancer ◽  
1988 ◽  
Vol 62 (10) ◽  
pp. 2263-2266 ◽  
Author(s):  
Purvish M. Parikh ◽  
Bishan S. Charak ◽  
Shripad D. Banavali ◽  
Smriti B. Koppikar ◽  
Neelam Giri ◽  
...  
1987 ◽  
Vol 46 (6) ◽  
pp. 1029-1034 ◽  
Author(s):  
V R Gordeuk ◽  
G M Brittenham ◽  
M Hughes ◽  
L J Keating ◽  
J J Opplt

The Lancet ◽  
2009 ◽  
Vol 374 (9704) ◽  
pp. 1840-1848 ◽  
Author(s):  
Marvin A Konstam ◽  
James D Neaton ◽  
Kenneth Dickstein ◽  
Helmut Drexler ◽  
Michel Komajda ◽  
...  

1997 ◽  
Vol 35 (1) ◽  
pp. 41-52 ◽  
Author(s):  
William Bonnez ◽  
David Oakes ◽  
Allyson Bailey-Farchione ◽  
Anna Choi ◽  
Dawn Hallahan ◽  
...  

Author(s):  
Niklas I. Nielsen ◽  
Henrik Kehlet ◽  
Kirill Gromov ◽  
Anders Troelsen ◽  
Henrik Husted ◽  
...  

1987 ◽  
Vol 151 (5) ◽  
pp. 639-642 ◽  
Author(s):  
J. Vallejo ◽  
C. Gasto ◽  
R. Catalan ◽  
M. Salamero

In a 6-week double-blind trial, the efficacy of imipramine and high dose phenelzine were compared in the treatment of Major Depression with Melancholia, and Dysthymic Disorder (DSM-III). Both drugs were found to be equally efficacious in the treatment of 32 patients suffering from Major Depression. In 32 Dysthymic patients, phenelzine in high doses was found to be superior to imipramine. The clinical implications of these findings are discussed.


Sign in / Sign up

Export Citation Format

Share Document